Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand.
A small but variable subgroup of patients with myasthenia gravis (MG) who have antibodies to muscle-specific kinase (MuSKAb-MG) can present with distinct phenotypes and are often treatment-resistant. The prevalence, clinical phenotypes and outcomes of treatment of patients with MuSKAb-MG in Thailand...
Asıl Yazarlar: | Witoonpanich, R, Dejthevaporn, C, Pulkes, T, Tunlayadechanont, S, Boonkongchuen, P, Pongpakdee, S, Vincent, A |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2013
|
Benzer Materyaller
-
Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand
Yazar:: Witoonpanich, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013) -
A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
Yazar:: Keritam, O, ve diğerleri
Baskı/Yayın Bilgisi: (2024) -
Antibodies against muscle-specific kinase in juvenile myasthenia gravis.
Yazar:: Anlar, B, ve diğerleri
Baskı/Yayın Bilgisi: (2003) -
A clinical perspective on muscle specific kinase antibody positive myasthenia gravis
Yazar:: Omar Keritam, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01) -
Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
Yazar:: Vincent, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)